Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Alectos |
Description | Toggle Navigation Home Company Pipeline Pipeline Our Science News News Publications Employment Contact Home Administrator 2022-06-20T14:32:03-07:00 Alecto |
Keywords | N/A |
WebSite | alectos.com |
Host IP | 67.195.197.25 |
Location | United States |
Site | Rank |
US$2,637,017
Last updated: 2023-05-13 17:19:09
alectos.com has Semrush global rank of 4,013,741. alectos.com has an estimated worth of US$ 2,637,017, based on its estimated Ads revenue. alectos.com receives approximately 304,272 unique visitors each day. Its web server is located in United States, with IP address 67.195.197.25. According to SiteAdvisor, alectos.com is safe to visit. |
Purchase/Sale Value | US$2,637,017 |
Daily Ads Revenue | US$2,435 |
Monthly Ads Revenue | US$73,026 |
Yearly Ads Revenue | US$876,302 |
Daily Unique Visitors | 20,285 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
alectos.com. | A | 295 | IP: 67.195.197.25 |
alectos.com. | NS | 86400 | NS Record: yns2.yahoo.com. |
alectos.com. | NS | 86400 | NS Record: yns1.yahoo.com. |
alectos.com. | MX | 300 | MX Record: 10 mx-biz.mail.am0.yahoodns.net. |
alectos.com. | TXT | 300 | TXT Record: i=268&m=geo-g5-mx2-p11 |
Toggle Navigation Home Company Pipeline Pipeline Our Science News News Publications Employment Contact Home Administrator 2022-06-20T14:32:03-07:00 Alectos Therapeutics PIPELINE OUR SCIENCE Who We Are Alectos Therapeutics discovers novel treatments to block the underlying progression of neurodegenerative diseases. Alectos identifies and develops innovative strategies to address complex neurological conditions, including Alzheimer’s disease and Parkinson’s disease. The Alectos pipeline is focused on creating new therapeutics to treat patients living with these disorders. Our GBA2 program is a disease-modifying approach to correct lysosomal dysfunction in neurodegenerative diseases, including Parkinson’s disease. This program has recently been partnered with Biogen. Our OGA program is a strategy to prevent the accumulation and spread of toxic protein aggregates in the brain. Alectos partnered with Merck to pioneer the development of the first clinical OGA inhibitor. Alectos has |
Domain Name: ALECTOS.COM Registry Domain ID: 1121281624_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.tucows.com Registrar URL: http://www.tucows.com Updated Date: 2021-07-02T05:15:33Z Creation Date: 2007-07-31T00:35:51Z Registry Expiry Date: 2022-07-31T00:35:51Z Registrar: Tucows Domains Inc. Registrar IANA ID: 69 Registrar Abuse Contact Email: domainabuse@tucows.com Registrar Abuse Contact Phone: +1.4165350123 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: YNS1.YAHOO.COM Name Server: YNS2.YAHOO.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-25T08:37:41Z <<< |